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The aim of in-vivo skin dosimetry is to measure the absorbed dose to the skin
during radiotherapy, when treatment planning calculations cannot be relied on. It
is of particularly importance in hypo-fractionated stereotactic modalities, where
excessive dose can lead to severe skin toxicity. Currently commercial diodes for such
applications are not available for medical physicists. In this study, we investigate a
new detector for skin dosimetry based on a silicon epitaxial diode, referred to as the
skin diode.
The skin diode is manufactured on a thin epitaxial layer and packaged using the
“drop in” technology. It was characterised in terms of percentage depth dose, dose
linearity and dose rate dependence and benchmarked against the Attix ionisation
chamber. The response of the skin diode in the build-up region of the percentage
depth dose (PDD) curve of a 6 MV clinical photon beam was investigated. Geant4
radiation transport simulations were used to model the PDD in order to estimate the
water equivalent measurement depth (WED) of the skin diode. Measured output
factors using the skin diode were compared with the MOSkin detector and EBT3
film at 10 cm depth at isocentre and at surface of a water equivalent phantom. The
intrinsic angular response of the skin diode was also quantified in charge particle
equilibrium conditions (CPE) and at the surface of a solid water phantom. Finally,
the radiation hardness of the skin diode up to an accumulated dose of 80 kGy using
photons from a Co-60 gamma source was evaluated.
The PDD curve measured with the skin diode was within 0.5% agreement of
the Geant4 simulated curve. When placed at the phantom surface, the WED of
the skin diode was estimated to be 0.075 ± 0.005mm from Geant4 simulations and
was confirmed using the response of a corrected Attix ionisation chamber placed at




The output factor measurements at 10 cm depth were within 2% of those mea-
sured with film and the MOSkin detector down to a field size of 2 × 2cm2. The
dose response for all detector samples was linear with R2=1 and with a repeata-
bility within 0.2%. The skin diode intrinsic angular response showed a maximum
deviation of 8% at 90 degrees and from 0 to 60 degree is less than 5%. The radiation
sensitivity reduced by 25% after an accumulated dose of 20 kGy but after was found
to stabilise. At 60 kGy total accumulated dose the response was within 2% of that
measured at 20 kGy total accumulated dose.
This work characterises an innovative detector for in-vivo and real-time skin
dose measurements that is based on an epitaxial silicon diode combined with the
CMRP “drop in” packaging technology. The skin diode proved to have a water
equivalent depth of measurement of 0.075 ± 0.005mm and the ability to measure
doses accurately relative to reference detectors.
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Chapter 1
Introduction
In vivo dosimetry is the most direct method for monitoring the dose delivered to the
patient receiving radiation therapy. Quality assurance of radiotherapy treatments
involves several techniques and diversified approaches to verify that the dose deliv-
ered by the machine is accurate in intensity and position; in vivo dosimetry checks
the dose delivered to the patient rather than the individual components prior to
treatment.
Monitoring of the skin dose helps to prevent that an excessive dose is delivered
to healthy tissues such as the skin. 20% of women undergoing 3D conformal radio-
therapy for breast cancer treatments develop acute skin toxicity which dramatically
affects the quality of life of the patient. [1]-[2] So ideally a dosimeter should be po-
sitioned at the point of interest inside a patients body or alternative on the surface.
ICRP defines skin dose as the dose absorbed and measured at the water equivalent
depth (WED) of 0.07mm [3] which makes estimation of skin dose challenging.
An ideal skin dosimeter should have extremely thin sensitive volume covered
with tissue equivalent build-up providing a WED of 0.07 mm for skin dosimetry or
even less if surface dose measurement is required.
Although the reference instrument for surface dosimetry at the air-to-water in-
terface is the parallel plate extrapolation ion chamber, it is not used routinely for
skin dosimetry. [4] The Attix ionisation chamber (IC) instead is often used for ac-
curate surface dosimetry and correction factors used to correct the response to the
skin WED. [5] Cylindrical IC are normally unsuitable for this application because
of their large diameter, thick entrance window and large beam perturbation. Un-
guarded parallel plate ICs show an overresponse at very shallow depths due to the
lateral secondary electrons scattering into the sensitive volume. [6]
1
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For this reason, only large diameter ring-guarded ICs such as the Attix ionising
chamber (Model 449 CNMC Co. Nashville, TN USA) are commonly considered as
the reference instrument for interface dose measurement. Although very accurate for
in-phantom measurements, the Attix IC can be used for skin dosimetry in a phantom
only; they are limited to measure large field size beams of 5×5cm2 and above [7]and
they have been never manufactured in array for skin 2D dose mapping.
Radiochromic films have an excellent spatial resolution, tissue equivalency and
can provide 2D dosimetric information. However, as radiochromic film is a passive
detector, it does not allow for real-time measurements. Its response may also be
affected by a WED of measurements much large than 0.07mm [8], improper handling
and scanner performance. [9]
Thermal Luminescence dosimeters (TLDs) have been used clinically for skin
dose measurements in their carbon-loaded version. They are small in size and tissue
equivalent however they require a long series of pre- and post-irradiation processes
and a refined calibration procedure to be readout accurately. They are labour in-
tensive and not real-time dosimeters, rendering them impractical for use in real-time
in-vivo skin dosimetry. [10][11]
Zhuang and Olch showed that a nano-dot Optically Stimulated Luminescence
Dosimeter can be adopted as skin dosimeter with stablisation delay of less than
10minutes after irradiation. However it has an effective WED of 0.8mm which is
larger than WED of 0.07mm accepted for skin dosimetry. [12]
Semiconductor detectors such as MOSFETs are able to achieve excellent spa-
tial resolution because of their high sensitivity and small sensitive volumes. The
MOSkin, based on the MOSFET technology and recently introduced by CMRP, are
also able to produce real time readout and provide a reproducible water equivalent
depth of dose measurement of 0.07 mm. [13] MOSkin has demonstrated good agree-
ment with the Attix IC for surface dose measurements and angular dependence in
MV and kVp photon beams. [14]However, due to their limited linear dynamic range
(up to 50Gy) they are not practical to use in a 2D array.
Silicon diode detectors could represent a good candidate to develop a new tech-
nology to measure in real-time in vivo skin dose. The technology development of
silicon diodes makes them the standard reference dosimeter for a variety of appli-
cation in radiotherapy from quality assurance of stereotactic modalities to in-vivo
dosimetry due to their small size allowing for high spatial resolution and high sensi-
tivity. [15][16] However, current designs of silicon diodes die and packaging, which
provides electronic equilibrium conditions for MV field of interest, do not make them
suitable for direct skin dosimetry on medical linacs.
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The purpose of this thesis is to perform a full characterisation of a silicon epitax-
ial diode detector for surface dosimetry in a phantom. The experimentation involved
includes: (i) detector calibration, linearity and reproducibility; (ii) percentage depth
dose; (iii) field size dependence; (iv) angular dependence, (v) dose per pulse depen-
dence and (vi) radiation hardness. In order to provide consistency and reliability
the results were compared with Monte Carlo simulations, ionisation chambers and
film.
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Radiation dosimeter is a device that measures absorbed dose resulting from inter-
actions of ionising radiation with matter. It is the determination of radiologically
relevant quantities such as exposure, KERMA, fluence, dose equivalent, energy im-
parted and so on. A dosimeter along with its reader is referred to as a dosimetry
system. The use of modern radiotherapy techniques such as EBRT (External Beam
Radiation Therapy) requires a new generation of radiation dosimeters that can be
used for in vivo skin dosimetric purposes and are able to provide real-time dosimetric
information whilst being small in size and volume.[17][18]
2.1.1 Dosimetric Quantities
Absorbed dose is a non-stochastic quantity that applies to both indirectly and di-
rectly ionising radiations. In the case of indirectly ionising radiations, the energy is
imparted to matter in a two-step process. The first step results in kerma, a mech-
anism by which indirectly ionising radiation transfers energy as kinetic energy to
secondary charged particles. The second step results in absorbed dose where the
charges particles will transfer some of their kinetic energy to the medium and thus
lose some of their energy in the form of radiative losses through Bremsstrahlung.
Absorbed dose is related to the stochastic quantity energy imparted, which can be
defined as the mean energy (ε) imparted by ionising radiation to matter of mass (m)
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The energy imparted (ε) is the sum of all the energy entering the volume of
interest minus all the energy leaving the volume, taking into account any mass
energy conversion within the volume. dε is the energy imparted on an infinitesimal
volume dV, with dm being a mass in dv. Pair production decreases the energy by
1.022MeV, while electron-positron annihilation increases the energy by the same
amount. Absorbed dose has units of Gray (Gy), where 1Gy is the absorption of
1J/kg (Joule/kilogram) of matter.[19]
The International Commission on Radiological Protection (ICRP) defines equiv-
alent dose as a “limiting quantity” in which exposure limits are specified to ensure
that “the occurrence of stochastic health effects is kept below unacceptable levels
and that tissue reactions are avoided”. [20] It is a measure of the radiation dose to
tissue where an attempt has been made to allow for the different relative biological
effects of different types of ionising radiation which is shown in table 2.1.[21]
Radiation Type Radiation weighting factor, wR
Photons 1
Electrons and muons 1
Protons and charged pions 2
Alpha particles, fission fragments, heavy ions 20
Neutrons Continuous function of neutron energy
Table 2.1: Recommended radiation weighting factors.
It is impractical to measure equivalent dose, thus calculated values may be used
to compare the equivalent dose with observed health effects. The equivalent dose
is calculated as a sum taken over all types of radiation doses. The absorbed dose
deposited in the body tissue or organ, T, is multiplied by the radiation weighting
factor, wR, which is dependent on the type and energy of the radiation, R. This
then takes into account the contributions of the varying biological effect of different






HT is the equivalent dose absorbed by tissue, T.
DT,R is the absorbed dose in tissue, T, by radiation type, R.
wR is the radiation weighting factor defined by regulation.
Since wR is dimensionless, the unit for the equivalent dose is the same as for
absorbed dose, J/kg however with a special name of Sieverts, Sv.[20]
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Effective dose can be defined by ICRP as the sum of the equivalent doses in
the principal tissues and organs in the body, each weighted by a tissue weighting
factor, wT . This weighting factor takes account of the probability of fatal cancer,
the probability of non-fatal cancer, weighted for severity, and the average length of
life lost due to an induced cancer [22].
ICRP emphasises that the effective dose provides a measure of radiation detri-
ment for protection purposes only. It does not provide an individual-specific dose
and should not be used for epidemiological evaluations [20].
The recommended tissue weighting factors are defined in table 2.2.
Tissue Tissue weighting
factor wT
Sum of wT values
Bone-marrow (red), colon, lung, stom-
ach, breast, remainder tissues*
0.12 0.72
Gonads 0.08 0.08
Bladder, oesophagus, liver, thyroid 0.04 0.16




Table 2.2: Recommended tissue weighting factors [20].
*Remainder tissues: Adrenals, extrathoracic (ET) region, gall bladder, heart,
kidneys, lymphatic nodes, muscle, oral mucosa, pancreas, prostate (male), small
intestines, spleen, thymus, uterus/cervix (female).
Effective dose can be calculated through the sum of the equivalent doses in all














HT or WRDT,R is the equivalent dose in a tissue or organ, T.
WT is the tissue weighting factor.
Effective dose and absorbed dose have the same units J/kg which is given the
name Sieverts, Sv.[20]
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2.1.2 Skin Dosimetry
The skin is the largest organ in the body and is very sensitive to radiation. The most
sensitive part of the skin is the epidermis and the basal layer of the epidermis which is
located at 0.07mm below the skin surface. According to ICRP publication 59 [3] this
is considered to comprise the most radiosensitive epithelial cells. It is essential that
potential early and late effects of the radiotherapy treatment are assessed accurately
to limit exposure to normal tissue from unnecessary irradiation. Therefore an ideal
in vivo dosimeter should possess the following characteristics:[13]
(i) tissue equivalent;
(ii) being re-usable;
(iii) small in physical size and has a small sensitive volume;
(iv) features (eg temperature, energy) which are consistent and characterisable;
(v) does not perturb the radiation field;
(vi) non-hazardous to humans;
(vii) deliver accurate and reliable dose results at the required depth and
(viii) able to provide real-time dosimetric information.
2.1.3 In-Vivo Dosimetry
In radiotherapy in-vivo dosimetry is the measurement of the radiation dose that
is received by the patient during treatment. In-vivo dosimetry in external beam
radiotherapy, is performed on the surface of the patients body to measure entrance
dose and skin dose. It is the most direct method for monitoring the dose delivered to
the patient and is a useful tool for quality assurance. It is able to detect major errors
associated with dosimetric errors such as human error in data generations and data
transfer and also equipment malfunctioning, assess clinically relevant differences
between planned and delivered dose, record dose received by individual patients,
and fulfil legal requirements. A well-developed in-vivo dosimetry plan will provide
precautions without significantly extending treatment delivery time.[10][23]
In-vivo dosimetry can also be used to monitor irradiation for special techniques
such as total body irradiation or total skin electron irradiation. Recommendations
regarding radiation dose delivery are provided by the International Commission of
Radiation Units and Measurements (ICRU) stating that the radiation dose to be
delivered should be within 5% of the prescribed dose. It is thus recommended that
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the total error in dose delivered at the end of the planning and treatment “chain”
should be less than 5%.[24]
In-vivo dosimeters can be divided into two categories: real-time detectors and
passive detectors. These two types of dosimeters require a calibration that is gener-
ally obtained by comparing their response against a calibrated ionisation chamber
(IC) in a known radiation field. Most of these detectors have a response that is
energy and/or dose rate dependent and consequently require adjustments of the re-
sponse to account for changes in the actual radiation conditions compared to the
calibration situation. Correction factors should be taken into account due to these
dependencies: changes in field size, source-detector distance, temperature, pressure
and orientation, and including the presence of a build-up cap. More so the presence
of a build-up cap is important for detectors that are used for entrance or exit IVD
(in vivo dosimetry). Special attention should be paid to the selection of appropriate
build-up cap material and thickness for entrance dose measurements during EBRT
as the dose beneath the dosimeter may be significantly attenuated by the dosimeter
build-up material. For that reason entrance dose measurements are often limited
to a few fractions. Furthermore when moving away from the reference conditions
the material and thickness of the build-up cap has an effect on the magnitude of
correction factors.[10]
2.2 Detectors used in Dosimetry
2.2.1 TLD Devices
Thermoluminescence is a thermally activated phosphorescence. It is widely known
for the number of different ionising radiation induced by a thermally activated phe-
nomena. [19] Thermoluminescence dosimetry is based on imperfect crystals being
able to absorb and store the energy of ionising radiation, which upon heating is re-
emitted in the form of electromagnetic radiation, mainly in the visible wavelength
spectrum. The light is emitted then detected by a photomultiplier and correlated
to the absorbed dose received by the TL material.[25]
The energy states in the crystal are represented with energy increasing upwards
along the ordinate. Free electrons and holes are produced under the irradiation
effect and both of them are free to travel through the solid in the conduction band
for a short period of time. They may be ultimately trapped at defects, or fall
back into the valence band and recombine either radiatively (fluorescence) or non-
radiatively with holes, or be captured at luminescent centres with the emission of
CHAPTER 2. LITERATURE REVIEW 9
light. The states just below the conduction band are the electron traps, and the
states just above the valence band are hole traps. The trapping levels are empty
before irradiation. The electrons may stay in the traps for prolonged periods, which
confer to the thermoluminescent method, the advantage of storage of information.
The information can then be collected by heating the crystal to a temperature
depending on its nature.
During irradiation the secondary charged particles lift electrons into the conduc-
tion band either from the valence band, which leaves a free hole in the valence band,
or from an empty hole trap, which fills the hole trap. The system may approach
thermal equilibrium through several means:
(i) free charge carriers recombine with the recombination energy converted into
heat;
(ii) a free charge carrier recombines with a charge carrier of opposite sign trapped
at a luminescence centre, the recombination energy being emitted as optical
fluorescence;
(iii) the free charge carrier becomes trapped at a storage trap, and this event
is then responsible for phosphorescence or the thermoluminescence and OSL
processes.[25]
For in-vivo measurements TL detectors have the advantage of being highly sen-
sitive under a small volume and do not to have to be connected to an electrometer
with a cable. Their major disadvantage is the time required for readout which can
be considerably decreased by a good choice of equipment and a good methodol-
ogy.[25]
TLD has become popular due to ease of use on the patient and the small physical
size of the dosimeter. They are particularly useful for measuring point doses, given
their small size and that information is stored permanently. However for surface
dose measurements with TLDs the thickness of the cover layer won’t allow one
to obtain the dose at a depth of 0.07mm, which is a potential disadvantage given
the importance of depth for a skin dose measurement. To combat this, a method
of extrapolation can be employed. By simultaneously using several thicknesses of
TLD the data collected from each can be drawn on to extrapolate the dose to the
required depth. Another technique for measuring skin dose is by using carbon loaded
(“black”) TLDs. The advantage of the black TLDs is the carbon absorbs all light
emitted within the TLD, except at the shallow surface layer. This can be adjusted
to suit the required depth of 0.07mm, thus facilitating the measurement of surface
doses.[25]
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The disadvantage of using TLDs is they require advance notice for sample prepa-
ration; frequent calibration is necessary, and TLDs are somewhat sensitive to envi-
ronmental conditions. TLDs also do not allow immediate readout, and they require
a lengthy annealing procedure. This makes their use time consuming during radio-
therapy. Further, the reproducibility of TLD measurements is relatively poor, which
requires several TLDs being irradiated and averaged, thus increasing the resources
required. [26]
2.2.2 Ionisation Chambers
Ionisation chambers are widely used in radiotherapy and in diagnostic radiology for
the determination of radiation dose. They have gained popularity due to their small
variation in response to energy, dose, dose rate and reproducibility[27] making them
the benchmark for calibration and comparison of other dosimeter detectors. More
so the size of some ionisation chambers makes them undesirable for measuring small
or narrow fields as the lack of lateral electronic equilibrium and the volume of the
chamber perturb the field of interest. [27] Thus making them undesirable as an
in-vivo dosimeter as they will show inaccurate results. Ionisation chambers require
a power supply which can be in excess of 200V for the ionised charge collection and
patient safety restricts them to use of phantoms only. [27]
Ionisation chambers come in various shapes and sizes depending on the specific
requirements; some include cylindrical (thimble type, eg Farmer type), parallel-plate
(e.g. Attix), and extrapolation chambers. The general characteristics for the various
ionisation chambers are a gas filled cavity that is surrounded by a conductive outer
wall which has two collecting electrodes: the anode and the cathode where the
anode is positively charged with respect to the cathode. The presence of radiation
will cause the charged particles to traverse the gas inside the ionisation chamber
creating ion pairs. The voltage potential applied across the chamber will cause
the electron of each ion pair to move to the anode while the positively charged
gas atom or molecule will move to the cathode thus creating an electronic pulse.
These individual pulses are too small to be detected and thus multiple radiation
interactions are easily detectable. An insulating layer is present in between the
wall and the collecting electrodes to reduce any current leakage when the polarised
voltage is applied. The accumulated charge is proportional to the energy of the
incident particles. [19][28]
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Cylindrical ionisation chambers are used for point-dose measurements in mega-
voltage photon radiation therapy due to their excellent stability, linear response
to absorbed dose, small directional dependence, beam-quality response indepen-
dence, and traceability to a primary calibration standard. The cylindrical ionisa-
tion chambers minimise the sensitivity response variation as a function of beam
entry angle when the beam central axis is perpendicular to the chamber axis of
symmetry.[29]
A parallel plate ionisation chamber is recommended for electron beam dosimetry
for energies below 10MeV. It is also used for surface dose and depth dose measure-
ments in the build-up region of photon beams however at the expense of directional
dependence in the case of full charged particle equilibrium. [19] The Attix parallel-
plate ionisation chamber is flat and very thin at 4.8mg/cm2 (25microns), with only
2mm separation between the plates. [30] The advantage that the Attix parallel-
plate ionisation chamber has over other chambers is the large guard ring that re-
duces over-response due to low energy electrons to less than 1%. [31][32]
Extrapolation chambers are parallel-plate chambers with a variable volume and
are used for surface dose measurements in orthovoltage and megavoltage x-ray beams
and in the dosimetry of beta rays and low energy x-rays. They can also be used in
absolute radiation dosimetry when it is directly embedded into a tissue equivalent
phantom. Cavity perturbation for electrons can be eliminated by making measure-
ments as a function of the cavity thickness and extrapolating to zero thickness. The
perturbation can be estimated by through using parallel-plate chambers of finite
thickness. [19]
To determine whether an ionisation chamber is functioning adequately, it should
be able to demonstrate a stable response over time where it can be compared
against a local secondary standard ionisation chamber for quality assurance pur-
poses.[29]
Throughout the experiment, the Attix parallel-plate ionisation chamber was
used as the benchmark standard for comparing different dosimeters.
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2.2.3 Radiosensitive Film
Film is capable of revealing a 2D dose map with good spatial resolution while ionisa-
tion chambers only display a point dose. Therefore, film is useful in radiation dosime-
try to observe dose distribution for treatment or for quality assurance testing of the
dose uniformity provided by the linear accelerator. There are two commercially
available options for 2D film dosimetry, which are radiographic and radiochromic
film.
Radiographic film serves as a radiation detector and a relative dosimeter that
is used for diagnostic radiology, radiotherapy and radiation protection. It provides
excellent 2D spatial resolution and in a single exposure provides information about
the spatial distribution of the radiation in the area of interest or the attenuation of
radiation by intervening object. [19]
Radiographic film is coated with silver bromide (AgBr) uniformly on one or
both sides of the base. When x-rays, gamma rays or light strike the grains of
sensitive AgBr, the Br- ions are liberated and captured by the Ag+ ions creating
a visual change in the film where the interaction took place. The degree of colour
change of the film is proportional to the amount of ionising radiation interacting
with the film at specific locations. Through this visualisation the cross sectional
profile of the beam that is being used can be seen. Radiographic film encounters
some disadvantages in that it does not allow for any real time dose measurements,
the useful dose range is limited, film batches can vary in sensitivity due to production
processes and the energy dependence is pronounced for lower energy photons up to
14-20 times more than compared to high energy photons. [29]. Even though there
are some present weaknesses with radiographic film it does present a convenient
option for two-dimensional dosimetry with its high spatial resolution and inexpensive
compared to radiochromic film. [28]
Radiochromic film is used in radiotherapy dosimetry, with the most common
being GafChromic film, which is colourless with a nearly tissue equivalent composi-
tion of 9% hydrogen, 60.6% carbon, 11.2% nitrogen and 19.2% oxygen that develops
into a blue colour upon exposure to radiation. [19] The film becomes polymerised
as it absorbs the light, displaying a blue effect on the film which is then detectable
by a densitometer. The effective depth of measurement for GafChromic film was
determined to be 0.153mm[33] which is larger than the required depth of 0.07mm
for skin dosimetry radiotherapy. However with appropriate correction, which is de-
pendent on field size, skin dosimetry of 0.07mm can be achieved.[33] It has a high
resolution and can be used in high dose gradient regions for dosimetry. In addi-
tion radiochromic film has a few advantages over radiographic film in the ease of
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usage through the elimination of the need for darkroom facilities, film cassettes or
film processing as they are self-developing, dose rate independence, better energy
characteristics (except for low energy x-rays of 25kV or less), and insensitivity to
ambient conditions. [19].
2.2.4 MOSFET
A metal-oxide semiconductor field effect transistor (MOSFET) dosimeter is similar
to diodes in that they belong to the same category of semiconductor detectors and
are built on a silicon substrate. It can be used for in-vivo dosimetry as it has a
water equivalent depth (WED) similar to that of the sensitive layer of the skin
at 0.07mm. MOSFETs consist of three electrical terminals: a source, drain and
gate. The source and drain are made from highly doped silicon n or p-type which
depends on the material of the substrate, if the source and drain are p-type silicon
then the substrate will be n-type silicon and thus called a p-channel MOSFET and
vice versa for n-channel MOSFET. [34] The gate, which is the third terminal, is on
top of an insulating silicon dioxide layer and underneath that layer is the silicon
substrate.[25]
Where a MOSFET dosimeter is used, the threshold voltage (VTH), which is
a sufficiently negative voltage is applied at the gate, can be determined when the
bias voltage is applied between the source and drain terminals in order to allow
a predetermined current, Ids , to flow. During irradiation of the MOSFET the
gate is kept at a positive bias which results in a charge separation effect in which
the electrons will tend towards the gate and the holes tend towards the Si-SiO2
interface. Due to the electrons being considerably faster, they will escape the gate
contact while the majority of the holes will remain at the Si-SiO2 interface and thus
captured in traps to produce a positive thin charge layer.[35][36][37]
Through this exposure to ionising radiation the holes, in relation to the electron-
hole pairs, are permanently trapped which will cause an alteration to the threshold
voltage. The threshold voltage should be recorded before and after irradiation in
order to demonstrate a voltage shift.
When a higher bias is applied during irradiation it will result in a larger pro-
portion of charges being collected, thus increasing the sensitivity of the device. The
sensitivity of the device is independent of the temperature during irradiation. As
the bias/sensitivity is increased the total dose that is able to be recorded before the
device is saturated and no longer useful is reduced. Hence when the MOSFET be-
comes saturated through over exposure of ionising radiation it will no longer produce
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accurate and reliable results thus resulting in a limited lifespan. [19][25]
The advantages of the MOSFETs are:[25]
 Relatively immediate response.
 No need for cables to connect the detectors on the patient to an electrometer;
however the gate must then be pre-biased before the irradiation.
 Small size (of the order of 1mm3).
 Good reproducibility: 2-3%.
 Non-destructive readout: possibility of study of dose accumulation over the
different treatment session, however with a fading correction.
 Response independent of dose-rate.
 Negligible angular dependence (±2% for 360 degrees).
The disadvantages of the MOSFETs are:[25]
 Response dependent on temperature except for dual base dosimeters; their
principle consists of associating 2 detectors with a different grid voltage and
of displaying the difference in their signals in order to produce temperature
compensated dosimeters.
 Response decrease as a function of accumulated dose, resulting in a limited
lifetime of the detector (of the order of 102 Gy in the usual conditions).
 Response dependent on energy: as for diodes, the basic material of a MOSFET
is silicon so that a similar energy dependence is observed.
 Slight loss of charge after irradiation: readings to be taken always at the same
time delay after termination of the irradiation.
A MOSFET-based dosimeter which was designed and prototyped by the Centre
for Medical Radiation Physics (CMRP) at the University Of Wollongong (UOW) is
known as the MOSkin detector. This detector is very similar to that of the usual
MOSFET detectors in that it is able to measure skin dose at 0.07mm, provides
real-time response, and built-in temperature compensation, which makes it suitable
for in-vivo skin dosimetry measurement. The design and packaging of the MOSkin
address issues within the traditional MOSFET dosimeters and improve the quality
and efficiency for clinical in-vivo skin dosimetry radiotherapy.
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2.2.5 Diodes
The operation of semiconductor diode dosimeters detectors are comparable to ion-
isation chambers however they are generally used without an external bias voltage
and are more sensitive for the same detection volume.[25]
Diodes that are used for in-vivo radiotherapy dosimetry are typically silicon de-
tectors and provide an advantage of immediate signal availability. [25] These diodes
are produced by taking n-type or p-type silicon and counter-doping the surface to
produce the opposite type material. The density of silicon and the low average en-
ergy required to form a carrier pair in silicon results in a radiation current density
which is about 18,000 times that of air. This allows a small volume (approx. 10−2-
10−1 mm3) of the silicon diode to produce an easily measured current, [16] as a result
diodes have a high sensitivity. Due to silicon having a considerably high atomic num-
ber of 14, the diode detectors will lead to a greater sensitivity to low-energy photons,
as the photoelectric effect cross-section is approximately proportional to Z5. There-
fore diode detectors should be used for small-field dose distribution measurements
where there are relatively few low-energy photons.[28]
The low-energy sensitivity of the diode can be reduced through introducing
a low-energy filter or shield within the construction of the diode; such a setup s
referred to as an “energy-compensated” diode detector. The key structure of the
silicon diodes is the p-n junction. The n-type silicon diode detectors are doped with
impurities of a pentavalent element such as phosphorous which are called “donor”
elements. Each of these donor elements contribute a free electron to the silicon
thus the majority carriers are the electrons and the minority carriers are the holes
in an n-type silicon diode detector. The p-type silicon diode detectors are doped
with impurities of a trivalent element such as boron which are called “acceptor”
elements. Each of these acceptor elements accept an electron that results in a mobile
hole in the silicon which is equivalent to a positively charged carrier. The majority
carriers are the holes and the minority carriers are the electrons in a p-type silicon
diode detector. Therefore p-type silicon diodes are formed by the donor impurities
being doped into a p-type substrate and the n-type silicon diodes are doped with
acceptor impurities in the n-type substrate. This creates a direct contact between
the p- and n-side of the diode. The majority carriers from each side will diffuse to
the opposite side such that electrons on the n-side will diffuse to the p-side leaving
behind positively charged donor ions, while the holes on the p-side will diffuse to the
n-side leaving negatively charged acceptor ions behind.[16] Through the transition
between both regions of p-type and n-type material a charge-free “depletion layer”
is formed in which an electrostatic potential difference is created which is about
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0.7V for a silicon diode. Hence as a result an electric field, E, is created over the
depletion layer and the diode will operate in an “unbiased” or “short-circuit” mode
as no external bias is applied to the diode to reduce leakage current [25]
As the diode becomes irradiated “electron-hole” pairs are created in the deple-
tion layer. Additionally, due to the high doping levels at the n-side of a p-type diode,
an abundant of crystal imperfections or “recombination centres” are present at that
side, which leads to a high probability of recombination for the holes. As a result
only the minority charge carriers, which are electrons in this case, will contribute
to the ionisation signal. Due to this process the charge equilibrium between n- and
p-sides of the diode are disrupted by the radiation.
The signal generated by the diode detectors originates mostly from secondary
electrons, which are produced by the incoming radiation beam outside the detec-
tors active volume where different materials create different quantities of secondary
electrons. Silicon diodes that are commercially available are found to have a large
change in sensitivity with the angle of incidence of radiation typically up to ±25%,
which is undesirable for dosimetry applications as it limits accuracy.
This creates a larger problem if the measured surface has an irregular shape,
which will cause the front of the diode to be oblique to the incident direction of
radiation. This will prohibit the use of this type of diode in any type of arc therapy.
In addition, a similar problem occurs if there is significant scattered dose from
adjacent surfaces. [15][38]
In-vivo dosimetry diodes are provided with build-up encapsulation that must be
appropriately chosen depending on the type and quality of a specific clinical beam.
The build-up cap used should guarantee that the detector is measuring under elec-
tron equilibrium conditions. Insufficient build-up requires the application of large
correction factors that can influence the accuracy of in-vivo dose measurements.
[23] Silicon diodes offer many advantages for in-vivo dosimetry, such as real- time
read-out, high sensitivity, simple instrumentation, reliability and robustness. How-
ever diode plus build-up cap response is subject to a number of influence factors
that need to be corrected for, such as the dependence of the signal on the dose
rate, the varying response with irradiation angle, and the energy dependence of the
response. Even for small variations in the spectral composition of radiation beams
the diode response may change, which is important for the measurement of entrance
and exit dose. Diodes show also a variation in response with temperature, however
some IVD diode systems provide for automatic patient temperature compensation.
Another disadvantage might be the need to handle the cables connecting the diodes
on the patient with the electrometer located outside the treatment room. However,
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in newer systems this problem has been overcome with wireless technology. Diodes
change their sensitivity after having accumulated sufficiently large doses and have
to be recalibrated regularly through a period of clinical use. [10]
2.3 Radiation Therapy
2.3.1 Introduction
Radiation therapy has been long recognised as an effective method for treating cancer
and depends on the accurate delivery of the absorbed dose in the patient. The goal
of radiotherapy, regardless of the delivery method, is to destroy the cancerous DNA
structures whilst minimising damage to normal healthy tissue, thus causing the
cells to die or to reproduce slowly or to cause mutations so future generations fail
to reproduce.[39]
IMRT is an advanced radiation delivery technique however is not the only one.
Other systems that are currently used are Tomotherapy, VMAT (Volumetric Mod-
ulated Arc Therapy), Rapid Arc, Gamma Knife and CyberKnife which are able to
deliver high dose/short fractionation course radiotherapy. All these systems have
the potential of delivering high skin dose.
The radiation dose is a prescription of dose depending upon the location and
type of cancerous tissue delivered to the patient in the specified target area. This
prescription of dose must minimise exposure to surrounding normal structures to
thus prevent any side effects.[39]
Radiation therapy utilises a range of beam spectra for treatment of specific tu-
mours with different energies. It can be delivered externally through external beam
radiation therapy machines or internally through placing a radioactive material in-
side the patient near the cancerous cells known as brachytherapy. External beam
radiation therapy can be classified through use of the energy of the beam being
utilised. Orthovoltage/superficial x-rays utilise the range of 30-500keV and are gen-
erally used for superficial, small tumours such as skin cancers as the lower photon
energies increase the photoelectric cross section and the probability of the photo-
electric effect interaction is greater, thus decreasing the penetrability of the beam.
Alternatively megavoltage x-rays within the range of 4-18MeV can be used for tu-
mours located deeper within the body at depths inaccessible for orthovoltage x-rays
to reach. Hence through increasing the range of the x-ray energies it also increases
the depth at which the maximum radiation dose is deposited. [28][40] A typical radi-
ation oncology department will treat about 80% of its patients with various external
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beam techniques and about 10-20% of its patients with brachytherapy.[19]
The basic principle of conformal radiotherapy is that tumour control can be im-
proved by using special techniques that allow the delivery of a higher tumour dose
while maintaining an acceptable level of normal tissue complications in compari-
son to standard dose delivery techniques. Intensity Modulated Radiation Therapy
(IMRT) is a type of conformal radiotherapy whereby the radiation dose volume is
conformed to the PTV while at the same time keeping the dose to specified or-
gans at risk below their tolerance dose. The conformal radiotherapy chain is based
on 3D target localisation, 3D treatment planning and 3D dose delivery techniques.
Therefore this allows increased tumour control probability and decreased treatment
morbidity (i.e. decreased normal tissue complication probability (NTCP)). Target
localisation is achieved through anatomical and functional imaging such as CT, MRI,
single photon emission computer tomography (SPECT), PET and ultrasounds. The
treatment planning system for IMRT is achieved through inverse planning which uses
intensity modulated beams to improve target dose homogeneity and spare organs
at risk, compared with standard forward planning techniques which design uniform
intensity beams shaped to the geometrical projection of the target. In forward
planning based treatment planning system (TPS), the user establishes beam direc-
tions, size and weight and the software produces Dose Volume Histograms based
on the beams arrangement. However in inverse planning bases TPS, the user sets
dose-volume constraints and priorities and the software optimizes the beam ballis-
tics that better meets these requirements. Dose can be delivery through intensity
modulated non-coplanar beams produced with multileaf collimators (MLCs). [19]
A MLC will adjust the size and shape of the radiation beam by adjusting the metal
leaves, usually made from tungsten, to block out areas and filter others to vary the
beam intensity and precisely distribute the radiation dosage.[19]
Although IMRT is a more precise delivery technique than other available tech-
niques. Any kind of radiation therapy carries with it inherit risks due to the nature
of the treatment. As such quality assurance (QA) and equipment verification sys-
tems are necessary in order to detect a malfunctioning medical accelerator or human
error during the planning phase or patient treatment. [41] It ensures consistency
of the medical prescription and safe fulfilment of that prescription, regarding the
dose of the target volume, together with minimal dose to normal tissue, minimal
exposure of personnel and adequate patient monitoring aimed at determining the
end result of the treatment. [19]
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2.3.2 Radiotherapy
External photon beam radiotherapy is usually carried out with more than one radi-
ation beam in order to achieve a uniform dose distribution inside the target volume
and an as low as possible a dose in healthy tissues surrounding the target. ICRU
Report No.50 [42] recommends a target dose uniformity within +7% and -5% of
the dose delivered to a well-defined prescription point within the target. Modern
photon beam radiotherapy is carried out with a variety of beam energies and field
sizes under one of two set-up conventions: a constant source to surface distance
(SSD) for all beams, or an isocentric set-up with a constant source to axis distance
(SAD). In an SSD set-up the distance from the source to the surface of the patient
is kept constant for all beams, while for an SAD set-up the centre of the target vol-
ume is placed at the machine isocenter. Clinical photon beam energies range from
superficial (30-80kVp), through orthovoltage (100-300kVp), to megavoltage energies
(Co-60 - 25MV). Field sizes range from small circular fields used in radiosurgery,
through standard rectangular and irregular fields, to very large fields used for total
body irradiation (TBI). [19]
2.3.3 High Energy Photons
The characterisation of a dosimeter is performed when the condition of charged
particle equilibrium (CPE) exists. Charged particle equilibrium (CPE) exists for
the volume (V) if each charged particle of a given type and energy leaving the
volume is replaced by an identical particle of the same energy entering the volume.
[17] Evidently when radiation equilibrium exists so does CPE, and the existence of
radiation equilibrium is a sufficient condition for CPE to exist. However for in-vivo
skin dosimetry detectors, the dosimeter should be characterised on the surface of
the patient instead of at the depth of maximum dose (dmax). The reason for such
characterisation of a dosimeter is due to the dosimetric condition of skin surface
and the build-up region being different to the dosimetric conditions at the depth of
maximum dose. There is a notable steep dose gradient in the build-up region at the
interface of two media (air and human tissue), which indicates that CPE does not
exist.[13]
As a single photon beam propagates through air or a vacuum it is governed by
the inverse square law, however as the photon beam transmits through a phantom or
patient it is not only affected by the inverse square law, but also by attenuation and
scattering of the photon beam. Thus a direct measurement of the dose distribution
inside the patient is a complicated process and essentially impossible, yet for a
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successful outcome of patient radiation treatment it is imperative that the dose
distribution in the irradiated volume be known precisely and accurately. This can
be achieved through the use of several functions that link the dose at any arbitrary
point inside the patient to the known dose at the beam calibration (or reference)
point in a phantom. A typical dose distribution on the central axis of a megavoltage
photon beam striking a patient can be shown in Figure 2.1 with several points and
regions identified. The beam enters the patient on the surface, where it delivers a
certain surface dose, Dsurface, defined at 0.05cm below the entrance surface. Dsurface
increases rapidly until it reaches the entrance dose (Dentrance) that is defined as dmax.
The target dose (Dtarget) is defined at the depth of dose specification which is equal
to the mean of Dentrance and Dexit. The dose then decreases almost exponentially
until it reaches the exit dose (Dexit) which is a value defined as the patients exit
point. The exit dose definition implies conditions of complete electron backscatter
as the dmax is larger than the electron backscatter range (s), however smaller than
the photon backscatter range (r).[19]
Figure 2.1: Schematic representation of the different doses involved in in-vivo
dosimetry for a single beam.[25]
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2.3.4 Single Beam Linac
Entrance Beam
The dose at which the entrance side of a medium is irradiated by a single photon
beam will gradually increase from a low value at the surface up to a maximum value
Dentrance at a depth of dmax. This increase is dependent upon a number of values
such as the energy, the opening of the collimator, the skin-to-source distance (SSD),
the introduction of beam modifying devices and the distance separating them from
the patient skin etc. The increase of a dose as a function of depth from surface to
dmax is steepest just below the surface and it gets less pronounced at larger depths
until it reaches dmax thereafter decreasing. Thus this relationship indicates that the
measurement of Dentrance should be conducted with enough material in front and
around the detector placed at skin level in order to be reproducible.[25]
The detectors used for in-vivo dosimetry have a sensitive layer approximately
1mm thick or less which indicates that when they are used on the skin the detector
will integrate the dose in a region of very steep dose gradient complicating the ratio
between dose to the detector and Dentrance. However, when a bare detector is used
it is subject to almost the full headscatter contaminating electron spectrum thus the
number of electrons increase as a function of the collimator opening and decrease
as a function of SSD. In order to limit the influence of headscatter electrons on
Dentrance, build-up caps are introduced with dimensions relative to the dimensions
necessary to ensure full build-up for the smallest collimator opening in the absence of
any accessory. Despite this, an issue can arise with higher energies as the thickness
of the build-up cap can be several centimeters of tissue-equivalent material thus
compromising the patient comfort and leading to an underdosage of the treatment
volume, combined with loss of skin sparing in large areas.
A way to reduce the build-up cap dimensions is to use a high density material and
all precautions should be taken to avoid errors and uncertainties such as calibrating
the detector with the build-up caps.
Incomplete build-up on an entrance detector might lead to certain correction fac-
tors which are only determined by the influence of the headscatter electron contam-
ination and not at all by the intrinsic characteristics of the detector type involved.
[25]
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Exit Beam
The dose delivered to the patient at the beam exit point is referred to as the exit
dose. At the exit side of the patient there is a build-down region related to lack
of backscatter radiation from the air behind the patient. Thus producing a dose
distribution curve that slightly decreases from the extrapolated dose distribution
curve. This lack of backscatter concerns photons as well as secondary electrons.
While the lack of electron backscatter causes a build-down of the dose only in the
latter few millimetres in front of the exit surface of the patient (approximately from
1mm for Co-60 to 3mm for 20MV x-rays, Lambert et al 1983), the lack of photon
backscatter influences a much deeper region and increases as a function of field size.
This relatively small effect is attributed to the missing scatter contribution at the
exit point from points beyond the exit dose.[25]
To derive the exit dose Dexit at dmax from the exit detector signal, it is necessary
to cover the detector with enough material behind and around it in order to ensure
complete electron backscatter (otherwise it would be too high a dose gradient, which
would decrease the accuracy). The ratio between the dose to the detector and the
exit dose has to be determined in a phantom in the same irradiation conditions
as for the patient. Mostly the in-vivo measurement of the exit dose is performed
concomitantly with that of the entrance dose. It is then important when positioning
the exit detector to avoid the shadowing effect of the entrance detector. [19][25]
Surface Dose
The surface dose for megavoltage photon beams is generally much lower than the
maximum dose which occurs at depth dmax , and depends on the beam energy and
field size. The larger the photon beam energy, the lower the surface dose, which for
a 10×10cm2 field typically amounts to some 30% of the maximum dose for a cobalt
beam, 15% for a 6MV x-ray beam and 10% for an 18MV x-ray beam. Thus the
surface dose increases with field size for a given beam energy. To measure the dose to
the skin which is defined at 0.05cm under the surface (ICRU, 1984) thin detectors
must be used. When the detectors are thin, such as monocoated photographic
emulsions, they should be covered with about 0.05cm of build-up material. However
for thick detectors, such as TL chips or thin layer of TL powder wrapped in envelopes
made of paper, they are to be placed on the skin without any build-up material.
Also correction factors have to be applied to their response when their effective
point of measurement is not at 0.05cm under their surface (Kron et al 1993). The
surface dose is measured with thin window parallel- plate ionisation chambers for
both polarities, with the average reading between the positive and negative polarities
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taken as the surface dose value. The surface dose represents contributions to the
dose from: [19][25]
 Photons scattered from the collimators, flattening filter and air;
 Photons backscattered from the patient;
 High energy electrons produced by photon interactions in air and any shielding
structures in the vicinity of the patient.
Build-up region
The build-up region results from the relatively long range of energetic secondary
charged particles (electrons and positrons) that are first released in the patient
by photon interactions (photoelectric effect, Compton effect, pair production) and
then impart their kinetic energy in the patient. The region immediately beneath
the patients surface, is where the condition of CPE does not exist and the absorbed
dose is much smaller than the collision kerma. However as the depth, z, increases,
CPE is eventually reached at z=zmax where z is approximately equal to the range
of secondary charged particles and the dose becomes comparable with the collision
kerma. Beyond zmax both the dose and collision kerma decrease due to the photon
attenuation in the patient, resulting a transient rather than true CPE. [19]
The build-up of absorbed dose is responsible for the skin sparing effect in the
case of high energy photon beams. However, in practice the surface dose is small
and does not equal zero due to the electron contamination in the beam from the
photon interactions in the media upstream from the phantom or due to charged
particles generated in the accelerator head and beam modifying devices.[19]
Depth of Dose Maximum
The depth of dose maximum zmax beneath the patients surface depends on the beam
energy and beam field size. The beam energy dependence is the main effect; the
field size dependence is often ignored as it represents only a minor effect. Nominal
values for zmax range from zero for superficial and orthovoltage x-ray beams, through
0.5cm for Co-60 beams, to 5cm for 25MV beams.[19]
For a given beam energy, the largest zmax occurs for fields of 5×5cm2 . For fields
larger than 5 × 5cm2, zmax decreases due to collimator scatter effects (cobalt units)
and collimator and flattening filter scatter effects (for linacs). For fields smaller than
5 × 5cm2, zmax decreases due to phantom scatter effects.[19]
Chapter 3
The Silicon Diode Detector and
Readout Systems
Diodes are represented as a two-terminal device, in that two electrodes are required
for a connection. [16] The two terminals of the diode can be connected to a coaxial
cable in two different configurations that result in either a positive or negative signal
from the diode detector. A negative diode detector is made by connecting the centre
conductor of the cable to the cathode of the diode, while a positive diode detector
connects the centre conductor to the anode of the diode. This choice does not affect
the performance of the detector and is made by the manufacturer to match the input
polarity requirement of the electrometer. [16] In the case of this experiment, the
diodes are constructed to provide a positive signal.
The silicon material in the diode is commonly referred to as the “die”. The
construction of the die, including size, the composition of the doping, the forming
of the p-n junction by diffusion and any lattice defects, either initially present or
caused by irradiation, determine some of the characteristics of the detector response
to radiation. The use of silicon as a material to be used as a radiation detector
for in vivo dosimetry provide some desirable characteristics. The features of silicon
include a low ionisation energy (3.6eV/pair) [43] indicating that a decent signal can
be obtained due to the sensitivity being high. There is a linear relationship between
the charged particle energy crossing the diode and the electron/hole pairs produced
along the track of the particle. Also, silicon has a long mean free path which allows
for good charge collection efficiency as there is a higher probability of the carrier
reaching the diode if created in the depletion region. [43]
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As the diode becomes irradiated “electron-hole” pairs are created in the deple-
tion layer and due to the high doping levels at the n-side of a p-type diode, an
abundant amount of crystal imperfections or “recombination centres” are present
at that side, which leads to a high probability of recombination for the holes.[25]
As a result only the minority charge carriers, which are electrons in this case, will
contribute to the ionisation signal and due to this process the charge equilibrium
between n- and p-sides of the diode are disrupted by the radiation. Thus, when
connecting both sides externally to each other, a current will be detected at radia-
tion, which when the diode is in the unbiased mode, is proportional to the number
of electron-hole pairs produced i.e. to the dose. [25]
The characterisation of dosimeters is normally performed where the charged
particle equilibrium (CPE) condition exists. [16][44][45]
However, characterisation of a skin dosimeter should be performed at the surface
and at very shallow depth in a build-up region where strong electronic disequilibrium
and steep dose gradient exist. Such conditions are typical for in vivo skin dosimetry.
[13]
3.1 Silicon Diode Detectors
The diodes that are used in this analysis are both silicon diode detectors of different
structures and composition p-type and n-type from CMRP at UOW and Fondazione
Bruno Kessler (FBK - Trento, Italy), respectively.
It is indicated that p-type diodes suffer less sensitivity loss as a function of
accumulated dose than their n-type counterparts and are said to be less dose-rate
dependent. [46] However n-type detectors are recently being modified to adapt
the characteristics for in vivo measurements. Thus, it can be determined from the
experiments, that are to follow, that the n-type silicon diode detector is an ideal in
vivo dosimeter.
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3.1.1 Epi-5B
Two epitaxial diodes were fabricated. The skin diode (named Epi-5B) was fabricated
by Fondazione Bruno Kessler (FBK - Trento, Italy) on an n-type silicon 5µm thick
epitaxial layer grown on a 0.001Ω-cm n-type silicon substrate. The detector structure
is represented in Figure 3.1 and is composed of boron implanted P+ sensitive area
of 0.5 × 0.5mm2, with a total size of the die of 0.75 × 0.75mm2. The effects of
the superficial leakage current are minimised by using a guard-ring surrounding the
entire pixel sensitive area.
Figure 3.1: Simplified top view diagram (not on scale) of the skin diode Epi-5B
topology.
Figure 3.2: Simplified cross section view diagram (not on scale) of the skin
diode Epi-5B topology.
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3.1.2 Epi-1C
To estimate the effect of the thickness of the epitaxial layer (sensitive volume) on
WED of dose measurement an epitaxial silicon diode was fabricated on a P-type
silicon 50µm thick epitaxial layer is grown on a 0.001Ω-cm P-type silicon substrate
(named Epi-1C see Figure 3.3). The Epi-1C has N+ phosphorus implanted active
area of 0.6×0.6mm2 and overall die dimensions of 1.5×1.5mm2. This diode has been
adopted for the fabrication of the 11 × 11 2D diode array MagicPlate. [13]
Figure 3.3: Simplified top view diagram (not on scale) of the skin diode Epi-1C
topology.
Figure 3.4: Simplified cross section view diagram (not on scale) of the skin
diode Epi-1C topology.
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Both these detectors were used for in vivo dosimetry experimentation and were
covered with Kapton tape material for both protection and build-up. The build-up
cap is used to guarantee that the detector is measuring under electron equilibrium
conditions. If there is insufficient build-up, this can influence the accuracy of in vivo
dose measurements, and large correction factors are to be implemented. [47]
More so both diodes had the presence of deep energy-level defects and trapped
charged at the Si-SiO2 interfaces, which also increases the leakage current. How-
ever, this effect is often mitigated by using the silicon detector in passive mode or
unbiased.
3.2 Detector Packaging
Both epitaxial diodes have been embedded in Kapton pigtails with 0.6×3mm2 cross
section and 350mm length using CMRP proprietary “drop-in” packaging technology.
“Drop-in” technology is a technique developed by the Centre for Medical Radiation
Physics (CMRP), University of Wollongong to design a dosimetric tool to be used for
Intensity Modulated Radiation Therapy (IMRT/VMAT) quality assurance.
This packaging technique is based on tab bonding of the silicon die underneath a
stack of polyamide and aluminium layers as illustrated in Figure 3.5. Therefore, the
build-up material thickness above the detector sensitive layer is reproducible and
providing WED of approximately 0.07mm. [48] The “drop-in” technology is com-
patible with standard flexible printed circuit manufacturing technologies and avoids
the use of high atomic number materials for packaging of semiconductor radiation
detectors, minimising the perturbation of the beam. The Kapton pigtail outside
of the diode is shielded by a thin aluminium foil and grounded to minimise radio-
frequency interference. [49] Further details on the “drop-in” packaging technology
can be found elsewhere.[14][38]
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Figure 3.5: Simplified schematic of the kapton pigtail cross section accommo-
dating the skin diode die using the “drop-in” packaging technology.
3.3 Data Acquisition System
The data acquisition system (DAS) used throughout the experiments enables the
detector channels to be read in real-time and across a wide dynamic range with
high linearity. It reads out the charge generated by the radiation beam into the
sensitive volume of the diodes and is based on multichannel electrometer connected
to a front-end which feeds the analogue to the digital data converters.
The extremely thin sensitive volume adopted for the skin diode Epi-5B requires
the use of a high sensitivity electrometer. The multichannel electrometer used for
this work is based on the AFE0064 which is a 64-channel analogue front end designed
and commercialised by Texas Instruments [50] to readout flat panel amorphous
silicon detectors. The AFE0064 is equipped with a double sampler for subtraction
of the baseline, which is a feature that has been adopted in this work for accurate
measurements of the charge collected in the volume of 1.25e-3mm3 of the epitaxial
diode.
The AFE0064 presents also a major advantage to be able to sample the detector
only when the beam is on, by the synchronisation of the detector sampling and the
analogue to digital conversion with the LINAC synch signal. Through this modality
it has a double advantage of minimising the effects of electronic noise and parasitic
current, and managing the dead time by reading out the data while the beam is off.
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It allows to read out integral charge on a 16-bit scale of 4.8pC, which corresponds
to measured charge resolution of 7e-5pC. The electrometer is read out by a USB
2.0 interface managed by a graphical interface installed into a standard laptop. For
further details on the electrometer architecture, please refer to [41].
Figure 3.6 displays a block diagram of the experimental setup depicting the
communication between the computer and the detector being used.
Figure 3.6: Simplified block representation of experimental setup.
3.4 Irradiation by megavoltage medical linear ac-
celerator
The measurements conducted were performed using the Varian Clinac 21Xi ma-
chine at the Illawarra Cancer Care Centre of Wollongong Hospital (NSW, Australia)
equipped with a multi-leaf collimator (MLC) Millennium-120 for 6MV photon beams
with a flattening filter. The linear accelerator utilises electromagnetic fields to pro-
pel charged particles to high energies. At the treatment head, the charged particles
are directed to a target consisting of a high Z number (such as tungsten), and the
subsequent radiation is directed through a series of collimators to deliver a precise
dose to the target volume. [51]
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The Linac was used to conduct the following measurements:
 Linearity of the detector over varying dose;
 Percentage Depth Dose of the detector;
 Dose Per Pulse Dependence of the detector;
 Angular Dependence;
 Output factor;
An ideal in-vivo diode dosimeter would display the following characteristics:
(i) Thin enough to determine dose delivered to shallow depths;
(ii) Resistance to radiation damage;
(iii) Reproducibility of WED (packaging);
(vi) Wide dynamic range;
(v) Linear dose response;
(vi) Insensitive to dose rate variations;
(vii) Energy and temperature independent;
(viii) Able to provide real-time dosimetric information.
The epitaxial diode detectors were irradiated with a Co-60 source at the Aus-
tralian Nuclear Science and Technology Organisation (ANSTO, Lucas Heights, NSW,
Australia) to study the effects of radiation damage on charge collection efficiency.
The effect of radiation damage on the degradation of radiation sensitivity of Epi-1C
epitaxial diode is presented in [52]. Reference [52] demonstrates the improvement
of the efficiency and long term stability of silicon dosimeters obtained by an n+ -p
junction surrounded by a guard-ring structure implanted on an epitaxial p-type Si
layer grown on a Czochralski substrate. The sensitivity of devices made up on 50µm
thick epitaxial Si degrades by only 7% after an irradiation with 6MeV electrons up
to 1.5kGy, and shows no significant further decay up to 10kGy. The passive epi-
taxial diode is usually less affected by accumulated dose due to the thin, sensitive
volume.
To stabilise the skin diodes response, they were pre-irradiated with dose incre-
ments of 20kGy up to a total accumulated dose of 80kGy with response measured
at each irradiation step.The radiation damage caused by continuous radiation is the
same as pulsed radiation. The response of the skin diodes is measured under stan-
dard conditions by delivering 100MU on 6MV linear accelerator photon beam, field
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size of 10 × 10cm2, at depth 1.5cm in a solid water phantom at a source to surface
distance (SSD) of 100cm. The error bars are calculated as one standard deviation
over five repetitions of the same measurement.
3.5 Attix Ionisation Chamber
Ionisation chambers are considered the reference tool for calibration and comparison
of other dosimeter detectors in radiotherapy. The reason behind their popularity
is due to their small variation in response to energy, dose, dose rate and their high
reproducibility. [27] However measuring small or narrow fields becomes a challenge
when using ionisation chambers as the lack of lateral electronic equilibrium and the
volume of the chamber perturbs the field.
Ionisation chambers have been extensively investigated over the years in partic-
ular by Das et al (2008) and the Institute of Physics and Engineering in Medicine
about structure and function.
The ionisation chamber that is used in this work is the Attix ionisation cham-
ber. The reason for using a parallel plate ionisation chamber over a cylindrical or
Markus ionisation chamber is that the Attix ionisation chamber is flat and thin
with dimensions of 4.8mg/cm3 and with the front electrode consisting of 0.025mm
Kapton conductive film and coating, and 2mm separation between the electrode
plates. [53][54] The Attix ionisation chamber provides a suitable geometry for sur-
face dosimetry, although at the expense of directional dependence in the case of full
charged particle equilibrium. The Attix ionisation chamber has a large guard-ring
13.5mm wide that reduces the over-response in the build-up region to less than 1%.
[55]
The table 3.1 shows the differences between a Cylindrical, Parallel-Plate and
Extrapolation ionisation chambers. [19]
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Ionisation Chamber Description
Cylindrical (Farmer type)
1. Measurements in mega-voltage photon radiation
therapy.
2. Excellent stability.
3. Small directional dependence.
4. Active volume between 0.1 and 1cm3 with internal
length no greater than 25cm and internal diameter
no greater than 7mm.
5. Wall material is tissue or air equivalent (low
atomic number, Z), with thickness less than
0.1g/cm2 and build-up cap thickness of about
0.5g/cm2.
6. 1mm diameter aluminium central electrode is used
to ensure flat energy dependence.
Parallel-Plate (Attix)
1. Recommended for electron beam dosimetry for en-
ergies below 10MeV.
2. Used for surface dose and depth dose measure-
ments in the build-up region.
3. Flat and very thin at 4.8mg/cm2 (25microns),
with only 2mm separation between the plates.
4. Large guard-ring to reduce over response due to
low energy electrons to less than 1%.
Extrapolation
1. Variable volume used for surface dose measure-
ments in orthovoltage and megavoltage x-ray
beams and in the dosimetry of beta rays and low
energy x-rays.
2. Used in absolute radiation dosimetry when it is di-
rectly embedded into a tissue equivalent phantom.
3. Cavity perturbation for electrons can be elimi-
nated by making measurements as a function of
the cavity thickness and extrapolating to zero
thickness.




The purpose of radiation damage characterization tests is to determine the change of
sensitivity of dosimetric devices with accumulated dose. When exposed to ionizing
radiation, silicon diodes become subject to radiation damage effects with varying
severity reliant on the incident particles used and their energy. These effects act as
recombination-generation centres, with equivalent energy levels located in the deep
forbidden gap and hence diminish the sensitivity of the detector and reduce the
minority carriers lifetime. [56]
Thus as the diffusion length is reduced the sensitive volume of the diode is
reduced, and the effect of radiation damage on silicon diodes has been shown to
decrease the diode sensitivity. [56] More so there is a specific requirement that
medical radiation detectors are to be as stable as possible during their life to avoid
frequent and time-consuming recalibration procedures. To circumvent the issue
of frequent recalibration and the decreasing sensitivity with accumulated dose the
silicon diode would need to be implanted into an epitaxial layer. This reduces the
active depth to values that are shorter than the minority carrier diffusion length
at the highest operative dose and by defining the planar active area by using a
guard-ring structure that is grounded during the operation. Thus when a change
in response properties occurs with respect to delivered dose by photon or electron
MV energy radiotherapy beams it generally becomes an issue that can be alleviated
through pre-irradiation to stabilise the response of the detector.[56]
34
CHAPTER 4. METHOD 35
Radiation damage is a necessary property of a dosimeter to avoid as their per-
formance will be altered with the accumulation of dose. However, if a dosimeter is
hardened it will be stable after an initial dose, independent of any further accumu-
lated dose.
To produce a radiation hardened device, several techniques have been introduced
in the detector design. These include manufacturing devices on insulating substrates,
shielding, choosing substrates with a wide gap for higher tolerance to deep level
effects as well as the introduction of bi-polar integrated circuits. [28]
Commercial silicon detectors have a sensitive volume in the region of 1 − 10 ×
10−2cm3, while commercial ionisation chambers have a sensitive volume in the region
of 1 × 10−1mm3. [57]
The measurements for this experiment have all been performed using the Varian
Clinac 21Xi Medical Linac at the Illawarra Cancer Care Centre at Wollongong Hos-
pital (NSW, Australia) equipped with a multi-leaf collimator (MLC) Millennium-120
by 6MV photon beams with a flattening filter. The irradiation of the epitaxial diode
probes for studying the radiation damage effects on charge collection efficiency of
the skin diodes has been performed using a Co-60 source at the Gamma Technol-
ogy Research Irradiation (GATRI) facility at the Australian Nuclear Science and
Technology Organisation (ANSTO, Lucas Heights, NSW, Australia). The effect of
radiation damage on the degradation of radiation sensitivity of Epi-1C epitaxial
diode is presented in Bruzzi et al. (2007). The passive epitaxial diode is usually less
affected by accumulated dose due to the thin sensitive volume and the radiation-
generated (RG) centres having a larger capture cross-section for holes than for elec-
trons. Therefore, during radiation exposure, more RG centres are occupied by the
minority carriers (holes) in an n-type than in a p-type diode (where the minority
carriers are electrons). [16]
To stabilise the response of the skin diodes, they were pre-irradiated with dose
increments of 20 kGy up to a total accumulated dose of 80 kGy with response
measurements taken at each irradiation step. The response of the skin diodes was
measured under standard conditions by delivering 100MU on 6MV linear accelerator
photon beam, field size of 10 × 10cm2, at depth 1.5 cm in a solid water phantom at
a source to surface distance (SSD) of 100 cm. The error bars are calculated as one
standard deviation over five repetitions of the same measurement.
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4.2 Dose Linearity
The linear response of the detectors are investigated under the standard conditions
of a 6MV photon beam with a field size of 10×10cm2 and a 1.5cm depth in a Virtual
Water Phantom (Standard Imaging Inc., Middleton, WI). The response of the diodes
are recorded from 50cGy up to 500cGy. The uncertainty is calculated by two stan-
dard deviations over three consecutive measurements of each of the three samples
from the same production batch and packaged with the same technology.
The investigation proposed by Van Dam et al (2005) and Meyer et al (2001)
indicates that as the dose is doubled so is the concentration or response of the
detector. Thus the expected signal is said to increase linearly as a function of dose
up to 10Gy for commercial semiconductor dosimeters.
4.3 Dose Per Pulse Dependence
The measurement of dose per pulse dependence (DPP) refers to the evaluation of
the change of the detector sensitivity due to the change of the instantaneous dose
rate in a pulsed radiation beam typical of a medical linear accelerator. [46] It was
reported by Rikner and Grusell [46] that n-type silicon diodes are more sensitive
to dose per pulse variation than compared to p-type silicon detectors, thus showing
an increase in sensitivity with increasing dose per pulse.The reason behind this is
that there is a greater reduction in unoccupied radiation-generated centres in an n-
type than in a p-type diode, hence allowing for more charge collection and a larger
increase in sensitivity with dose rate.
Therefore, an evaluation of the diode characteristics is vital to determine if the
technology adopted for the Epi-5B skin diode can be used for quality assurance
on a medical linac. The DPP was performed by measuring the diodes and the
Attix chambers response placed at a 1.5cm depth and irradiated with a 10× 10cm2
field of 6MV photon beam at 600MU/min within the phantom and varying the
SSD from 100cm up to 250cm. The ratio between the charge measured by the
silicon diode to the charge measured by the Attix ionisation chamber represents
the DPP dependence of the detector which is normalised to the dose per pulse of
2.78 × 10cm−4Gy/pulse corresponding to the SSD of 100cm. This method avoids
variation of the spectrum of the radiation and can be used to characterize only the
dose rate dependence assuming that the ion chambers dose per pulse dependence is
within ±1%. [58]
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4.4 Percentage Depth Dose
The percentage depth dose (PDD) measurements are obtained for both the silicon
epitaxial diode detectors, Epi-5B (n-type) and Epi-1C (p-type), and compared to
the Attix ionisation chamber.
The detectors were placed individually in a recess machine of a Virtual Water
slab to ensure consistency of the scattering conditions. A 10cm thick slab of 30 ×
30cm2 solid water phantom was used for back-scattering, and several slabs of solid
water phantom ranging from 0.1cm to 20cm are used to place on top of the detectors
to obtain the depth dose profiles. The detectors were irradiated with 6MV photon
beams of 100MU with a 10×10cm2 field size at 100cm SSD for all thicknesses. Thus
the SSD is not changing and kept at 100cm in order to accurately measure the PPD
for all thicknesses. The results are compared to measurements taken by the Attix
ionisation chamber under the same experimental conditions. All the detectors were
first pre-irradiated at dmax and then normalised to dmax.
Additional depth dose profiles were obtained for the skin diode Epi-5B with the
epitaxial layer of the skin diode facing downwards. This was conducted under the
same experimental conditions as when the diode was facing up as described above
to determine whether orientation of the detector affects the PDD results.
Monte Carlo Geant4 version 10.0.p01 [59] simulations were performed to deter-
mine the dose distribution at the build-up region generated by the specific linac
adopted for this experimental evaluation of the skin diode performances. The in-
cident 6 MV x-ray beam of dimensions 10 × 10cm2 passing through a 30 × 30 ×
30cm3water equivalent block phantom was modelled using Geant4. The source-to-
surface distance (SSD) was 100 cm, and the beams were fired from phase space files
created from an EGSnrc Monte Carlo based system that models the Varian 2100C
Linac at Illawarra Cancer Centre in Wollongong (Australia). The model used to
represent the Linac and the phantom setup, along with the physics of transport, has
been already validated by experimental results previously. [60] The physics processes
modelled in the simulation are from the Geant4 electromagnetic standard physics
package and include photoelectric effect, Compton scattering and gamma conver-
sion (photons), ionization, Bremsstrahlung, and positron annihilation (leptons). The
particle range cut is set to 0.1mm and the electron/positron maximum step length
is 0.1mm. Dose is scored inside the phantom at a voxel size of 0.02 × 1 × 1mm3.
Each simulation is split into ten parallel jobs each with unique seeds and the mean
dose reported. The standard deviation is taken across ten simulations to evaluate
uncertainties. In total, 4 × 1013 primary histories are simulated where the primary
histories represent the number of electrons hitting the x-ray target in the Linac
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head.
The dose uncertainty is approximately ±0.5% of the dose at 1.5cm depth at the
beam central axis (CAX) for the 10 × 10cm2 field size.
4.5 Output Factor and surface field size depen-
dence
The output factor is defined as the ratio of dose per monitor unit at a specific field
size to the reference field size.[61]
Output factors are among the clinical beam properties that enter the absorbed
dose calculations to a patient on radiation treatment. The procedure in output
factor measurements itself is quite simple to follow as it is a point measurement
(i.e. one which is done at a point where the detector is static in the medium). The
output factors are also quantities that are most problematic to measure in small
photon fields since large variations in the measured values are predominant.
The field output factors of high energy x-ray machines describe the relative
variation of dose with the size of a beam aperture or field collimation; the larger the
field size is the larger the dose at a point in a phantom it becomes. [62] The output
factor is defined as the ratio of dose in water, Dw , for a given beam collimator
aperture, A, at a reference depth, d, to the dose at the same point and depth, d, for





For this study the reference field size is 10×10cm2, which is measured at isocentre
and at a depth of 10cm (SSD is 90cm), irradiated with 100MU each time. The output
factor is measured through placing the pre-irradiated skin diodes (60kGy irradiation
dose by Co-60) in the centre of the field for field sizes varying the jaws aperture
from 2 × 2cm2 to 30 × 30cm2. The alignment of the detector has been performed
by maximising the detector response for the 2 × 2cm2 beam by a scan in the SUP-
INF and lateral directions using the couch positioning system (spatial resolution
of ±1mm). A measurement of the field factor at surface of the phantom has also
been performed to evaluate the capabilities of the detector to measure surface dose
as a function of the field size defined by the jaws. The silicon epitaxial diodes are
benchmarked using Gafchromic EBT3 film, the Attix ionisation chamber and the
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MOSkin, frequently used for interface measurements and described in several works.
[48][63][64]
The films were calibrated using 1.5 × 1.5cm2 cuts and scanned using a flatbed
scanner (Epson 10000XL scanner; Epson America, Inc. Long Beach, CA) 24 hours
after irradiation to allow for post-irradiation development. The films were scanned in
transmission mode, at a resolution of 72 dpi and 48 bit RGB data format. Analysis
of three scanning repetition for each film placed with the same orientation have been
performed using ImageJ 1.46r software (National Institute of Health, Bethesda, MD)
and one standard deviation of the optical density used as uncertainty. A template
was used to scan the films at the centre of the scanner bed to avoid non-uniformity
associated with the position of the film in respect to the scanner lamp or sensor.
Only the red channel was used for analysis of a region of interest (ROI) at the centre
of the film. The films used to perform the measurements have been pre-scanned for
evaluation of the background optical density and to take care of the non-uniformities
associated with the specific film cut. Butson et al. provides in depth details of the
preparation and scanning procedure adopted for the analysis of the EBT3 film.
As a result of the small field dosimetry for both the p- and n-type silicon diode
detectors, a severe over-response can affect the outcome due to the lack of lateral
charged particle equilibrium.[61] This occurs when the beam source radius becomes
small in comparison to the maximum range of secondary electrons. Thus, resulting
in disequilibrium which renders the assumptions of the Bragg-Gray cavity theory
ineffective. There is also an underestimation of dose when the field sizes are small
due to the heightened sensitivity of the silicon diode detectors to scattered radiation
(2% for 2 × 2cm2 field size).[65]
4.6 Angular dependence
The angular dependence of the n-type skin diode (Epi-5B) response was measured
experimentally to determine whether angular positions of the linac affects the re-
sult and function of the detector. This characteristic is of high importance when
performing off-axis measurements. It has been suggested by Shi et al. (2003) that
the more “oblique” the radiation, i.e. the larger the angle between the beam axis
and the diode symmetry axis, the angular dependence becomes higher, which may
amount to more than 5% for angles of 60 degrees and greater. [25]
The angular dependence obtained for the response of the Epi-5B detector was
evaluated under two different conditions. The first condition being that the Epi-
5B detector was placed in a cylindrical PMMA phantom at 15cm depth (aligned
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with the central axis of the phantom) and placed at isocentre with a field size of
10 × 10cm2 of a 6MV photon beam. The response of this detector was normalised
to 0 degrees corresponding to the beam perpendicular to the detectors face-up con-
figuration.
The second condition corresponds to the detector being placed at surface of a
30×30cm2 Virtual Water Phantom with 10cm of backscattering. This configuration
benchmarked the Epi-5B detector to the Attix ionisation chamber, after correction
of its intrinsic angular dependence, using a field size of 10 × 10cm2 at 100cm SSD
for a 6MV photon beam.
For both conditions 100MU was delivered for each gantry angle position rotating
from -60 degrees to +60 degrees in 15 degree increments and responses normalised




The skin diode (Epi-5B) is fabricated on a 10Ω-cm n-type silicon substrate which
is potentially sub-optimal for radiation detectors exposed to high energy photon
radiation for extended periods. The radiation damage associated with therapy pho-
ton beams is mainly from the recoil energy of secondary electrons. The radiation
damage with electron beams is due to the energy transfer by of primary and scat-
tered electrons to the silicon crystal lattice. The use of the detector in passive mode
mitigates the problem associated with the leakage current increase. This increase
is due to the accumulation of generation and recombination centres in the silicon
substrate and the trapped charge at the silicon-silicon oxide interfaces. The residual
radiation damage effect is the variation of the detector response as a function of the
accumulated dose.
Figure 5.1 demonstrates the variation of the response of the n-type silicon skin
diode detector (Epi-5B) as a function of the dose accumulated from the Co-60 gamma
source. As expected there is a response decrease with accumulated dose. However,
the response becomes stable with a variation of approximately -0.05%/kGy after
60kGy. The response decreases by a factor of 25% in the first 20kGy of accumulated
dose due to the reduction of the carrier lifetime and shrinking of the diffusion length.
This result mainly affects the charge generated around the P+ junction coming
from lateral directions. As soon as the diffusion length is shorter than 30-50µm,
the collection of the charge stabilises, making the detector response variation within
2%. The result is in agreement with previous results on thinned and epitaxial silicon
detector studies on a substrate with similar resistivity by Bruzzi et al. (2007) and
Petasecca et al. (2007). Also consistent with data mentioned by Larin et al. (1968),
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Rikner and Grusell (1983) and Van Dam et al. (1990) as that there is a loss in
sensitivity as a function of the dose which accumulates over the diode detectors
lifetime.
Figure 5.1: Response variation of the skin diode (Epi-5B) as a function of
accumulated dose from a Co-60 gamma source.
5.2 Dose Linearity
Figure 5.2 presents the dose linearity for the accumulated dose varying from 50cGy
to 500cGy for Epi-5B and Epi-1C epitaxial diodes after pre-irradiation by 60kGy,
respectively. Both these diodes display a linear relationship between the dose and
detector response over a 500MU range, which is an expected characteristic when
using diode detectors.
Table 5.1 summarises the dose calibration factors from charge to dose extracted
from the linearity measurements. The conversion factor demonstrates that despite
the sensitivity of Epi-5B it is very low in comparison with the thicker epitaxial
diode Epi-1C, its reproducibility is still within 0.2% with excellent linearity (R2=1
for Epi-5B). The reproducibility of the diode detectors is determined based on two
standard deviations of five repeated measurements of each accumulated dose.
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Figure 5.2: Dose linearity response for the Epi-5B (squared symbol) and Epi-1C
(dotted symbol) epitaxial silicon diodes.
Diodes R2 Response (pC/cGy)
Epi-1C 0.9999 115.18 ± 0.14
Epi-5B 1.000 53.12 ± 0.03
Table 5.1: Dose calibration factors of the Epi-5B and Epi-1C.
5.3 Dose per pulse dependence
Figure 5.3 demonstrates the dose per pulse dependence (DPP) response of the 5B
n-type epitaxial detector. The response is normalised to the dose measured by the
ion chamber from a 6MV photon beam at 2.78 × 10cm−4Gy/pulse and at 1.5cm
depth in solid water with a beam field size of 10 × 10cm2 and 100cm SSD. Dose
rate dependence in silicon diodes can potentially affect the capability of the de-
tector to reconstruct accurately dose profiles and depth dose distributions. The
skin diode shows a variation of less than 5% within the range between 10−4 and
2.78 × 10cm−4Gy/pulse. The percentage depth dose measurements present a ±1%
agreement compared to the parallel plate ion chamber.
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Figure 5.3: Dose per pulse (DPP) response of the skin diode Epi-5B estimated
at Dmax (1.5cm) in solid water with a 6MV photon beam of 10×10 cm2 field size
varying SSD from 100cm to 250cm.
The epidiode 5B detector exhibited an increase in response as the dose rate
(Gy/pulse) increased. This is explained by the Shockley-Read-Hall (SRH) recom-
bination model which is the recombination and generation of holes and electrons in
semiconductors that occur through the mechanism of trapping.[16]
More so, as the instantaneous dose-rate increases, due to treating a short SSD,
the rate of minority carrier generation also increases. Thus, if the recombination-
generation centre concentration is insufficient, then the diode sensitivity also in-
creases as a larger fraction of the charge produced by the radiation. The charge is
then available to be collected by the electrometer. For linacs, dose is delivered in
pulses of approximately 100 pulses/second of width approximately 2-6µs and the
instantaneous dose rate within a single radiation pulse determine the rate of charge
generation. This is shown in Figure 5.3
AAPM RPT 87 states that all diode detectors exhibit a change in sensitivity
with SSD and that the changes in SSD will change the instantaneous dose rate,
thus changing the probability of indirect recombination. [16] It is also important to
note that the average dose rate, which is nominally 100-600cGy/min is not the same
as the instantaneous dose rate in an accelerator pulse which is 103-104cGy/min.
[16] This dose rate is 102-103 times higher than the average rate because the charge
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collection time of the diode and electrometer is typically much shorter than the time
between the pulses. In addition, the response of an in vivo dosimetry system is not
expected to depend upon the average dose rate.
During the irradiation of diode detectors, electron-hole pairs are produced at a
rate that increases as a function of dose-rate (dose per unit time). When the dose-
rate is high as is the case for pulse radiation produced by linear accelerators, pile up
occurs. This phenomenon arises when the ions are produced at such a high rate that
the recombination cannot continue and more charge carriers escape recombination
than at lower dose-rates. Therefore, diode sensitivity decreases when decreasing the
dose per radiation pulse. This has been observed for both n- and p-type detectors
(Grusell and Rikner, 1983).
In relation to the dose per pulse test, as the SSD increases, the sensitivity of the
detector decreases by 50% for a 10-fold increase in dose rate (Gy/pulse) reduction
thus altering the probability of indirect recombination.
5.4 Percentage Depth Dose
Figure 5.4 presents a comparison of the percentage depth dose (PDD) measurements
from surface to 20cm depth in Virtual Water with the skin diode and the Attix
ionisation chamber. The results are normalised to dmax for a 6MV photon beam with
10×10cm2 radiation field area. The observed maximum difference between the PDD
measured with the skin diode and calculated with Geant4, excluding the outsider
point at 1cm depth, is within ±2% with an agreement within +0.5% at a water
equivalent depth of 0.07mm. The difference between skin diode and the uncorrected
Attix chamber at 0.07mm depth is approximately +2%. This difference reduces to
0.2% if the ion chamber response is corrected for skin dosimetry as suggested by
Gerbi and Khan implying an effective depth of measurement for the un-corrected
Attix chamber of approximately 30µm. [54][33]
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Figure 5.4: Percentage Depth Dose measured by the skin diode in comparison
to the Attix ionisation chamber with no build up cap and no correction factors
applied.
Figure 5.5: Comparison of the same data set measured with Attix and Epi-5B
with the simulations performed by the means of Geant4 in water and represented
in logarithmic scale of the depth in water.
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Figure 5.6 displays the comparison of the PDD measured in standard conditions
between the thick epitaxial Epi-1C diode and the Attix ionisation chamber in Virtual
Water. The observed maximum difference between the PDD measurements is +5.5%
representing an over-response of the epitaxial Epi-1C diode on a surface of the
phantom; while its agreement with the Attix ionisation chamber at depths greater
than 5mm is less than 1.5%.
This measurement has been performed to determine the sensitivity of the WED
of dose measurements to the thickness of the epitaxial layer for the fabrication of
an effective skin dosimeter with WED of dose measurement 0.07mm when placed
on a surface of the phantom, even if the diode utilizes the same “drop in” packag-
ing technology. Another example of the accuracy required for the design of a skin
dosimeter using silicon is shown in Figure 5.7, where the skin diode has been irradi-
ated face-down. Compared to the Attix ionization chamber, the face-down Epi-5B
over-responses has +20% more dose recorded at the surface.
In the face-down configuration, the diode substrate is irradiated before reaching
the sensitive volume. The different WED corresponding to this configuration gen-
erates a discrepancy in surface dose measurements of approximately +20%. This is
expected and can be observed in Figure 5.7 as the 400µm silicon above the sensitive
volume generates a build-up with WED of approximately of 1mm. This increased
detector response is due to the dose enhancement effect of the high Z of silicon,
i.e. additional number of electrons are forward scattered from the silicon substrate
to the sensitive volume of the epitaxial layer downstream. Thus, with decreasing
photon energies, this effect is gradually reduced as the competing effect of the x-ray
attenuation due to the 0.400mm silicon substrate.
The n-type and p-type epitaxial silicon diode detectors present a ±1% agreement
of the measured PDD compared to the parallel plate Attix Ionisation Chamber
downstream of dmax regardless of the substrate size. The thin substrate detector
used (n-type, 5B with 7µm substrate) shows an agreement with the Attix ionisation
chamber response at the surface within +1.7%. The thick substrate detector used
(p-type, 1C with 50µm substrate) demonstrates a large discrepancy up to +7% at
the surface. This effect can be related to the excess of charge contribution due to
the backscattering from silicon in thick devices which becomes predominant at low
depths due to the lack of charge particle equilibrium. More so when the orientation
of the detector is reversed for the epidiode 5B detector a discrepancy of +20%
at the surface compared with the Attix ionisation chamber is measured for the
PDD. However, downstream of dmax for this detector configuration, there is a 1.5%
discrepancy and 400µm silicon above the sensitive volume will generate a large build-
up thus indicating that orientation impacts the results when using a silicon detector
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diode for skin dosimetry.
The Geant4 simulations of the percentage depth dose in the build-up region
have been used to derive the effective WED of 0.07mm and 0.03mm of the skin
diode and the Attix ionisation chamber, respectively. The thickness of the sensitive
volume of the detector in steep dose gradients is a major factor for accuracy in
skin dosimetry at a water depth of 0.07mm. The Epi-1C detector with 50µm thick
epitaxial layer was found to have a WED of 1mm, making this diode unsatisfactory
for skin dosimetry. While the Epi-5B detector with a 7µm thick epitaxial layer
produced a WED of approximately 0.075mm, indicating that this diode is ideal for
skin dosimetry.
Figure 5.6: PDD measured by Epi-1C in comparison to Attix IC in a solid water
phantom Epi-1C is “face up”.
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Figure 5.7: PDD measured by Epi-1C in comparison to Attix IC in a solid water
phantom Epi-5B is “face-down”.
5.5 Output Factor and surface field size depen-
dence
Output factor is known as a function of the field size due to the factor that as the
field size increases, not only will the primary radiation increase however the number
of scattered radiation also increases. This results in a higher rate of ionization and
therefore a higher dose measured by the detectors. This is shown in Figures 5.8 and
5.9, which are normalised to the reference field size 10 × 10cm2.
Figure 5.8 displays the output factor measured by the skin diode and compared
to EBT3 film and MOSkin detector at 10cm depth within the Virtual Water phan-
tom. As expected, MOSkin and EBT3 film agree within 1.2% from a square field
size (SFS) of 0.5cm up to 30 cm proving the quality of the experimental setup which
confirms results obtained previously for small field dosimetry studies. [66]
The skin diode in the face-up configuration has been tested from an SFS of 2cm
up to 30cm with an agreement within 2% in respect to EBT3 film. The lack of data
below an SFS of 2cm is due to the very poor signal to noise ratio of the detector in
small field sizes at a depth of 10cm in the solid water phantom.
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Figure 5.9 shows the measurement of the surface field size dependence using the
Attix ionisation chamber and the skin diode normalised to a field size of 10× 10cm2
using different Kapton build-up layers. The configuration with 0.05mm of build-up
matches the skin diode response within 3% for all the field sizes investigated.
More so the response of the Epi-5B detector in a virtual water phantom is
determined by the secondary electrons. In the free air geometry, the diode response
is determined by photons, i.e. the mass energy absorption coefficients of the silicon.
[48]
Skin dose increases as a function of the field size and depends on the WED
measurement. The skin diode and the Attix ICs response with field size are different
due to the fact that the WED of the IC is about 0.025mm [33], in contrast to the
WED of the skin diode, estimated to be approximately 0.075mm. Adding two
Kapton sheets of 25µm thick, and matching field size response of the response of
the ionisation chamber to the skin diode confirms that the skin diode WED is
approximately between 0.07 and 0.08mm, as estimated by the Geant4 simulations.
Thus due to the small sensitive volume of the Epi-5B detector, it is advantageous
for small field surface dosimetry compared to Attix ionisation chamber.
The use of the skin diode for low dose rate measurements is challenging due
to the trade-off between a thin sensitive volume and the signal-to-noise ratio. This
was observed during output factor measurements, where measurements in fields
below 2 × 2cm2 were impossible with the electrometer adopted. Adapting a larger
area for the p+ top junction without enlarging the overall diode size by reducing
the external guard-ring would double the sensitivity of the sensor solving the issue
of the signal-to-noise ratio. This would increase the amount of charged collected
without perturbing the beam with a larger silicon die.
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Figure 5.8: Output factor measured by MOSkin, EBT3 film and skin diode
Epi-5B at 10cm depth in Virtual Water phantom.
Figure 5.9: Field size dependence of the skin diode placed at surface of the
phantom in comparison with Attix with different build up thickness.
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5.6 Angular dependence
The angular dependence response of the epitaxial silicon diode detector was studied
in the context of in vivo skin dose measurements. For surface dose measurements,
where CPE does not exist, it is important to note that the surface dose increases
with the beam incidence angle. Correct measurements of the skin dose at different
angles of beam incidence are valuable for both treatment planning system (TPS)
verification [13] and for studies correlating acute skin toxicity to dose delivered to
the skin in head and neck or breast cancer treatments.
The epitaxial 5B detector is a planar silicon device which suffers of an intrinsic
angular dependence. In order to accurately estimate the effect of skin dose deposition
from tangential beams, we must compensate for the intrinsic angular dependence
of the device. This can be achieved by testing the detector placed in the central
axis of a cylindrical PMMA phantom of radius 15cm and aligned with the linacs
isocenter.
Figure 5.10 shows the result for the intrinsic angular dependence of the Epi-5B
normalised to the response of the detector at gantry angle 0-degree (beam incident
orthogonally). As expected, the device behaves similarly to a planar device with a
very thin sensitive volume: the largest variation (-8%) occurs at 90 degrees and the
attenuation of the beam incident from the back-side of the detector is approximately
-2%. The correction factor for a tangential beam with angle of ±60% as expected
in a 3D conformal treatment of breast cancer will be +5% at largest.
To evaluate the ability of the skin diode to measure skin dose at various beam
incidence angles, 100MU of a 6MV photon beam with a 10 × 10cm2 field size is
delivered with the gantry position rotated from -60degrees to +60degrees with 15
degree increments. The skin diode and the EBT3 film are placed on a surface of
the phantom and their readings are normalised to the reading obtained at 0 degree
gantry angle with a fixed SSD of 100cm.
Figure 5.11 shows a comparison between the angular dependence response of the
skin diode (corrected for its intrinsic angular dependence), the film and the Attix
ionising chamber. As the beam incidence angle increases, the measured surface dose
increases as well, due to dmax being shifted towards the surface.
The skin diode with a 0.005mm epitaxial layer is suitable for skin dosimetry with
a WED of 0.075mm. The angular response at the surface of the phantom agrees
within 3% of relative variation between the skin diode and EBT3 film with beam
incident angles in the range between ±60 degree. The skin diode shows a minimal
angular dependence comparable with the film response, however it also measures the
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dose at the WED of 0.07mm which cannot be achieved by film. Film has a WED of
dose measurement at approximately 0.1mm due to the polyamide protection layer
above the radiation sensitive polymeric substrate (0.05mm thick) [13][67]. The Attix
IC response shows a large over-response up to +20% at ±60 degree as confirmed by
other studies. [5]
Figure 5.10: Normalised intrinsic angular response of the skin diode placed in
centre of a cylindrical PMMA phantom of radius of 15cm as a function of the
angle. Center of the phantom is placed in isocentre. Normal incident angle is 0
degree.
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Figure 5.11: Comparison of the normalized surface dose angular dependence
measured by the skin diode , EBT3 film and Attix chamber at surface of a Virtual
Water phantom for a 6MV photon beam.
Chapter 6
Conclusion and Future Work
Silicon diode detectors with different substrate thicknesses 50µm known as 1C and
7µm known as 5B are compared with the Attix parallel plate ionisation chamber
for different field sizes, percentage depth doses, angles, dose rate dependence and
radiation hardness to determine which detector is ideal for in vivo skin dosimetry.
An ideal in vivo dosimeter should have the following characteristics: (i) thin enough
to determine dose delivered to shallow depths; (ii) reproducibility of WED (water
equivalent depth) (packaging); (iii) wide dynamic range; (iv) linear in dose response;
(v) insensitive to dose rate variations; (vi) energy and temperature independent; and
(vii) able to provide real-time dosimetric information.[13]
This work presents a feasibility study towards the development of a silicon diode
that can measure the skin dose accurately in respect to clinical standards for QA
of medical linacs. The use of a diode for skin dose measurements is of interest due
to the possibility of developing an array of such detectors for real time, in-vivo skin
dose mapping in several radiotherapy and diagnostic imaging modalities, where the
risk of acute skin toxicity is a serious issue for the patients quality of life. The skin
diode is fabricated on a 0.005mm thick epitaxial silicon layer placed above 0.4mm
thick silicon substrate and embedded in a thin water equivalent package using “drop
in” packaging technology. The skin diode has a WED of 0.075 ± 0.005 mm, as
recommended by the ICRP and can be used to measure the skin dose delivered by
oblique radiation beams.
The skin diode can also be used for conventional QA dosimetry in radiation
therapy because it has a linear dose-response over a dynamic range from 25 to 500
cGy and minimal intrinsic angular dependence, in conjunction with the ability to
measure the PDD within 2% compared to ionisation chamber.
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The challenge to be addressed is the improvement of signal-to-noise ratio for
low dose rate applications, which could be achieved by increasing the sensitive area
of the skin diode and electrometer sensitivity. Such a device would be suitable as a
multi-purpose diode for real-time QA measurements in radiation therapy.
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